EV/EBITDA
-0.75
0.000.00%
103 min ago
Summary
- As of March 3, 2025, AKTX EV/EBITDA is -0.75, unchanged from the previous trading day.
- AKTX EV/EBITDA is now -334.38% below its all-time high of 0.32.
Performance
AKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | +1.1% | +1.0% |
| 1 m1 month | +26.5% | -25.9% | -24.8% |
| 3 m3 months | +33.6% | -33.1% | -31.8% |
| 6 m6 months | - | - | -76.0% |
| ytdytd | +28.6% | -28.5% | -27.3% |
| 1 y1 year | - | - | -61.4% |
| 5 y5 years | +74.1% | -58.2% | -97.7% |
AKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -1.18 | +36.4% | |
| 3 m | 3-month | -0.75 | at high | -1.28 | +41.4% |
| 6 m | 6-month | -0.75 | at high | -3.21 | +76.6% |
| 1 y | 1-year | -0.75 | at high | -4.27 | +82.4% |
| 3 y | 3-year | -0.16 | -368.8% | -4.69 | +84.0% |
| 5 y | 5-year | -0.16 | -368.8% | -7.52 | +90.0% |
| alltime | all time | 0.32 | -334.4% | -13.49 | +94.4% |
Akari Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.75(-28.6%) |
| 2024 | -1.05(-28.1%) |
| 2022 | -1.46(-59.4%) |
| 2021 | -3.60(+13.2%) |
| 2020 | -3.18(+60.6%) |
| Date | Value |
|---|---|
| 2019 | -1.98(+138.6%) |
| 2018 | -0.83(-23.1%) |
| 2017 | -1.08(-39.7%) |
| 2016 | -1.79(-25.7%) |
| 2015 | -2.41(-44.1%) |
| 2014 | -4.31 |
FAQ
- What is Akari Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akari Therapeutics?
- What is AKTX EV/EBITDA year-to-date change?
What is Akari Therapeutics EV/EBITDA?
The current EV/EBITDA of AKTX is -0.75
What is the all time high EV/EBITDA for Akari Therapeutics?
Akari Therapeutics all-time high EV/EBITDA is 0.32
What is AKTX EV/EBITDA year-to-date change?
Akari Therapeutics EV/EBITDA has changed by +0.30 (+28.57%) since the beginning of the year